Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117411212 | 11741121 | 2 | F | 20160805 | 20151116 | 20160812 | EXP | BR-ROCHE-1659027 | ROCHE | 0.00 | F | Y | 0.00000 | 20160812 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117411212 | 11741121 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 103976 | 2 | DF | SOLUTION FOR INJECTION | /month | |||||||
| 117411212 | 11741121 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 103976 | 2 | DF | SOLUTION FOR INJECTION | /month | |||||||
| 117411212 | 11741121 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 103976 | SOLUTION FOR INJECTION | ||||||||||
| 117411212 | 11741121 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 103976 | SOLUTION FOR INJECTION | ||||||||||
| 117411212 | 11741121 | 5 | SS | INFLUENZA VACCINE | INFLUENZA VIRUS VACCINE | 1 | Unknown | U | 0 | ||||||||||
| 117411212 | 11741121 | 6 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 117411212 | 11741121 | 7 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 300 MG (50 + 250 MG), QD | 0 | 300 | MG | QD | |||||||
| 117411212 | 11741121 | 8 | C | GLIFAGE | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117411212 | 11741121 | 1 | Asthma |
| 117411212 | 11741121 | 5 | Product used for unknown indication |
| 117411212 | 11741121 | 6 | Asthma |
| 117411212 | 11741121 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117411212 | 11741121 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117411212 | 11741121 | Anxiety | |
| 117411212 | 11741121 | Cholelithiasis | |
| 117411212 | 11741121 | Diabetes mellitus | |
| 117411212 | 11741121 | Feeling abnormal | |
| 117411212 | 11741121 | Feeling cold | |
| 117411212 | 11741121 | Hypertension | |
| 117411212 | 11741121 | Influenza | |
| 117411212 | 11741121 | Memory impairment | |
| 117411212 | 11741121 | Neck pain | |
| 117411212 | 11741121 | Nervousness | |
| 117411212 | 11741121 | Pain | |
| 117411212 | 11741121 | Pruritus | |
| 117411212 | 11741121 | Sneezing | |
| 117411212 | 11741121 | Spinal disorder | |
| 117411212 | 11741121 | Superficial vein prominence | |
| 117411212 | 11741121 | Swelling | |
| 117411212 | 11741121 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117411212 | 11741121 | 1 | 20070101 | 0 | ||
| 117411212 | 11741121 | 2 | 20120222 | 0 | ||
| 117411212 | 11741121 | 3 | 201605 | 0 | ||
| 117411212 | 11741121 | 4 | 201606 | 0 | ||
| 117411212 | 11741121 | 5 | 201605 | 201605 | 0 |